Evidence map›Paper›PMID 42395230›Full record

ArticleCureus2026

Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience.

Joseph I Berger, Anthony D Anderson, Octavio V Martinez, Michele I Morris, Mohammed Raja, Lazaros J Lekakis, Amer Beitinjaneh, Antonio Jimenez, Mark Goodman, Trent P Wang and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Joseph I BergerDivision of Infectious Diseases, University of Miami, Miami, USA.
Anthony D AndersonDivision of Pharmacology, Sylvester Comprehensive Cancer Center, Miami, USA.
Octavio V MartinezDivision of Pathology and Laboratory Medicine, University of Miami, Miami, USA.
Michele I MorrisDivision of Infectious Diseases, University of Miami, Miami, USA.
Mohammed RajaDivision of Infectious Diseases, University of Miami, Miami, USA.
Lazaros J LekakisDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Amer BeitinjanehDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Antonio JimenezDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Mark GoodmanDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Trent P WangDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Jay SpiegelDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Noa G HoltzmanDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Krishna V KomanduriDivision of Hematology and Oncology, University of California San Francisco Medical Center, San Francisco, USA.
Denise PereiraDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Damian GreenDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, USA.
Jose F CamargoDivision of Infectious Diseases, University of Miami, Miami, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose and methods Refractory and/or resistant herpes simplex virus (R/R HSV) mucocutaneous infections are an emerging challenge in immunocompromised hosts. A single-center retrospective study of R/R HSV mucocutaneous infections in allogeneic hematopoietic cell transplantation (HCT) was conducted on cases identified between 2023 and 2025. Cases were categorized using the 2025 consensus definitions. We collected data on the clinical presentation, risk factors, and outcomes and investigated the genetic mechanisms of resistance. Results Five cases of R/R HSV following HCT were identified. Four patients had documented

Indexed as

car-thematopoietic cell transplantationherpes simplex virusrefractoryresistant

Identifiers

PMID42395230
PMCPMC13327080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.